---
title: "$Compass Pathways(CMPS.US) is expected to be the first company to develop psilocybin therapy for TRD"
description: "$Compass Pathways(CMPS.US) is expected to be the first company to develop psilocybin therapy for TRD and PTSD, with great potential"
type: "topic"
locale: "en"
url: "https://longbridge.com/en/topics/35973622.md"
published_at: "2025-11-04T11:41:41.000Z"
author: "[新鲜猪头](https://longbridge.com/en/profiles/14716515)"
---

# $Compass Pathways(CMPS.US) is expected to be the first company to develop psilocybin therapy for TRD

$Compass Pathways(CMPS.US) is expected to be the first company to develop psilocybin therapy for TRD and PTSD, with great potential

### Related Stocks

- [CMPS.US - Compass Pathways](https://longbridge.com/en/quote/CMPS.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.